Full-Service, Fully Committed
CordenPharma, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), is a full-service Contract Development & Manufacturing Organization (CDMO) for the production of APIs, Drug Products, and associated Packaging Services. Through a growing network of focused investments across Europe and the US organized under Technology Platforms, CordenPharma experts translate complex processes, ideas and projects at any stage of development into high-value products.
CordenPharma’s vertically-integrated supply chain model provides development & manufacturing expertise spanning the complete cGMP supply chain > from regulated raw materials through intermediates, APIs, commercial-scale Drug Product manufacturing, finished dosage formulation, packaging, clinical trial services, & pharma logistics > resulting in reduced development & manufacturing time and cost.
News & Press
- September 14, 2020
COVID-19 > Read CEO Dr. Micheal Quirmbach's Customer Letter Response to COVID-19.
- July 07, 2020
Press Release > CordenPharma Increases US Peptide Manufacturing Capacity to Accommodate Global Market Growth
- June 30, 2020
Molecule to Market Podcast: A CDMO on the COVID-19 Frontline, with guest Dr. Michael Quirmbach
LIVE WEBINAR > Your Injectable Roadmap for Combined Drug Product-Device Regulations & Capabilities in the New Normal
TUES OCT 13 at 16:00 CEST / 10:00 EDT > REGISTER HERE
TIDES VIRTUAL 2020 > Sept 15-18
Please check our events page for trade show cancellations or rescheduled virtual dates.
Browse our library of Brochures, Product Lists, White Papers, Videos & Webinars.
Place an inquiry here > one of our team of experts will get back to you.